Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Annora Pharma
Hyderabad (nearby), Telangana, India
- Ownership
- Private
- Development stage
- Other
01
Overview
Annora Pharma operates a USFDA-approved plant; as of 2025, has 45 drugs approved by US regulators and 48 ANDAs approved globally, with 34 more ANDAs under review. Products primarily generic, spanning several major therapeutic areas, with expanding commercial portfolio, robust revenue growth, and continuous new filings.
- Therapeutic areas
- ImmunologyEndocrinologyPsychiatryMen's HealthInfectious DiseasesGastroenterologyPulmonologyDermatologyCardiovascularOncologyNeurology
- Modalities
- Small moleculeTabletCapsulePelletLiquid oralSuppositoryDry powder syrup
- Industry
- Biotech
02
Partnerships
Not disclosed in available sources; presumed global pharma distribution partnerships
Beyond the preview
Go deeper on Annora Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Annora Pharma.